Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ackerman

Showing results (531-540 of 643) with videos related to

Pageof 65
Sort By:
The Lancet. Infectious Diseases|September 18, 2016
Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infantsPeter F Wright, Ruth I Connor, Wendy F Wieland-Alter, et al.
Sports Medicine (Auckland, N.Z.)|September 6, 2025
Training Volume and Training Frequency Changes Associated with Boston Marathon Race PerformanceAlexandra F DeJong Lempke, Kathryn E Ackerman, Trent Stellingwerff, et al.
Frontiers in Microbiology|October 14, 2021
The Crossroads of Glycoscience, Infection, and ImmunologyTanya R McKitrick, Margaret E Ackerman, Robert M Anthony, et al.
The Journal of Infectious Diseases|September 9, 2015
λ Light Chain Bias Associated With Enhanced Binding and Function of Anti-HIV Env Glycoprotein AntibodiesMohammad M Sajadi, Maham Farshidpour, Eric P Brown, et al.
The Journal of Clinical Investigation|August 29, 2024
Discrimination of primary and chronic cytomegalovirus infection based on humoral immune profiles in pregnancyAndrew P Hederman, Christopher Al Remmel, Shilpee Sharma, et al.
European Journal of Sport Science|June 15, 2024
Minimal influence of the menstrual cycle or hormonal contraceptives on performance in female rugby league athletesElla S Smith, Jonathon Weakley, Alannah K A McKay, et al.
Mucosal Immunology|February 18, 2016
Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategiesM Sips, M Krykbaeva, T J Diefenbach, et al.
Nature Communications|February 4, 2022
Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysisDavid A Spencer, Benjamin S Goldberg, Shilpi Pandey, et al.
Medrxiv : the Preprint Server for Health Sciences|September 29, 2022
SARS-CoV-2 mRNA vaccination elicits broad and potent Fc effector functions to VOCs in vulnerable populationsAndrew P Hederman, Harini Natarajan, Joshua A Wiener, et al.
Retrovirology|October 31, 2021
Diverse antiviral IgG effector activities are predicted by unique biophysical antibody featuresHao D Cheng, Karen G Dowell, Chris Bailey-Kellogg, et al.
Pageof 65

Showing results (531-540 of 643) with videos related to

Sort By:
Pageof 65
The Lancet. Infectious Diseases|September 18, 2016
Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infantsPeter F Wright, Ruth I Connor, Wendy F Wieland-Alter, et al.
Sports Medicine (Auckland, N.Z.)|September 6, 2025
Training Volume and Training Frequency Changes Associated with Boston Marathon Race PerformanceAlexandra F DeJong Lempke, Kathryn E Ackerman, Trent Stellingwerff, et al.
Frontiers in Microbiology|October 14, 2021
The Crossroads of Glycoscience, Infection, and ImmunologyTanya R McKitrick, Margaret E Ackerman, Robert M Anthony, et al.
The Journal of Infectious Diseases|September 9, 2015
λ Light Chain Bias Associated With Enhanced Binding and Function of Anti-HIV Env Glycoprotein AntibodiesMohammad M Sajadi, Maham Farshidpour, Eric P Brown, et al.
The Journal of Clinical Investigation|August 29, 2024
Discrimination of primary and chronic cytomegalovirus infection based on humoral immune profiles in pregnancyAndrew P Hederman, Christopher Al Remmel, Shilpee Sharma, et al.
European Journal of Sport Science|June 15, 2024
Minimal influence of the menstrual cycle or hormonal contraceptives on performance in female rugby league athletesElla S Smith, Jonathon Weakley, Alannah K A McKay, et al.
Mucosal Immunology|February 18, 2016
Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategiesM Sips, M Krykbaeva, T J Diefenbach, et al.
Nature Communications|February 4, 2022
Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysisDavid A Spencer, Benjamin S Goldberg, Shilpi Pandey, et al.
Medrxiv : the Preprint Server for Health Sciences|September 29, 2022
SARS-CoV-2 mRNA vaccination elicits broad and potent Fc effector functions to VOCs in vulnerable populationsAndrew P Hederman, Harini Natarajan, Joshua A Wiener, et al.
Retrovirology|October 31, 2021
Diverse antiviral IgG effector activities are predicted by unique biophysical antibody featuresHao D Cheng, Karen G Dowell, Chris Bailey-Kellogg, et al.
Pageof 65